NewsBot
03-14-2022, 01:11 AM
FDA center director: "We want people that look like us on this trial."
The post FDA Slows Approval of Affordable Cancer Drug in the Name of Racial ‘Equity’ (https://www.amren.com/news/2022/03/fda-slows-approval-of-affordable-cancer-drug-in-the-name-of-racial-equity/) appeared first on American Renaissance (https://www.amren.com).
More... (https://www.amren.com/news/2022/03/fda-slows-approval-of-affordable-cancer-drug-in-the-name-of-racial-equity/)
The post FDA Slows Approval of Affordable Cancer Drug in the Name of Racial ‘Equity’ (https://www.amren.com/news/2022/03/fda-slows-approval-of-affordable-cancer-drug-in-the-name-of-racial-equity/) appeared first on American Renaissance (https://www.amren.com).
More... (https://www.amren.com/news/2022/03/fda-slows-approval-of-affordable-cancer-drug-in-the-name-of-racial-equity/)